Steven Sciuto Director, Finance
contact name: Steven Sciuto
contact job function details: finance
contact job function: finance
contact job title: Director, Finance
contact job seniority: director
contact person city: New York
contact person state: New York
contact person country: United States
contact person zip code:
business name: Acorda Therapeutics, Inc.
business domain: acorda.com
business facebook URL: https://www.facebook.com/AcordaTherapeutics/
business linkedin: http://www.linkedin.com/company/30583
business twitter: https://twitter.com/AcordaNews
business website: http://www.acorda.com
uruguay 500,000 telegram number
business angellist: http://angel.co/neuronex
business found year: 1995
business city: Ardsley
business zip code: 10502
business state: New York
business country: United States
business language: English,English,English
business employee: 440
business category: biotechnology
business specialty: developing & commercializing therapies that improve the lives of people with nervous system disorders, spinal cord injury, stroke & epilepsy also developing a therapeutic approach for chronic heart failure, including multiple sclerosis, biotechnology
business technology: mailchimp_mandrill,office_365,amazon_aws,kissmetrics,typekit,new_relic,facebook_web_custom_audiences,mobile_friendly,facebook_widget,asp_net,google_adwords_conversion,sharethis,on24,recaptcha,jw_player,google_font_api,google_analytics,microsoft-iis,google_tag_manager,facebook_login,doubleclick,wistia,google_dynamic_remarketing,doubleclick_conversion,mailchimp_mandrill,office_365,amazon_aws,google_tag_manager,kissmetrics,google_font_api,typekit,asp_net,jw_player,wistia,microsoft-iis,new_relic,google_analytics,mobile_friendly,doubleclick,sharethis,recaptcha,on24,mailchimp_mandrill,office_365,amazon_aws,google_tag_manager,kissmetrics,google_font_api,typekit,doubleclick,sharethis,asp_net,jw_player,wistia,microsoft-iis,new_relic,google_analytics,mobile_friendly,recaptcha,on24
business description: Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson?╟╓s disease, migraine and multiple sclerosis
